Pandemic

Jiumaojiu Announces 2023 Annual Results

Retrieved on: 
Friday, March 22, 2024

HONG KONG, Mar 22, 2024 - (ACN Newswire) - Jiumaojiu International Holdings Limited ("Jiumaojiu" or the "Company" and its subsidiaries (together, the "Group"); Stock Code: 9922HK) is pleased to announce the audited consolidated results of the Company for the year ended December 31, 2023.

Key Points: 
  • HONG KONG, Mar 22, 2024 - (ACN Newswire) - Jiumaojiu International Holdings Limited ("Jiumaojiu" or the "Company" and its subsidiaries (together, the "Group"); Stock Code: 9922HK) is pleased to announce the audited consolidated results of the Company for the year ended December 31, 2023.
  • As of December 31, 2023, the Group had a total of 578 Tai Er restaurants, 62 Song Hot Pot restaurants, 77 Jiumaojiu restaurants, 1 Uncle Chef restaurant, 7 Lai Mei Li Grilled Fish restaurants and 1 Fresh Wood restaurant.
  • In addition, revenue from Song Hot Pot as a percentage of total revenue increased from 6.5% in 2022 to 13.5% in 2023.
  • In 2023, the Group experienced accelerated growth in both its restaurant operations and delivery services revenue.

Model Medicines Unveils Groundbreaking AI Drug Discovery Advances in New Chemistry and New Biology with Two New Preprint Papers

Retrieved on: 
Tuesday, April 9, 2024

LA JOLLA, Calif., April 9, 2024 /PRNewswire/ -- Model Medicines, a leading human health company specializing in generative AI-driven drug discovery, today announced the publication of two significant preprint papers on bioRxiv detailing major advances in antiviral and oncology drug discovery.

Key Points: 
  • LA JOLLA, Calif., April 9, 2024 /PRNewswire/ -- Model Medicines, a leading human health company specializing in generative AI-driven drug discovery, today announced the publication of two significant preprint papers on bioRxiv detailing major advances in antiviral and oncology drug discovery.
  • Using bioinformatics and deep learning, they also found MDL-001 to be a promising orally bioavailable broad-spectrum antiviral that blocks the RdRp Thumb-1 site.
  • In the second preprint, "ChemPrint: An AI-Driven Framework for Enhanced Drug Discovery" , Model Medicines details their foundational GALILEO AI platform and its core ChemPrint deep learning model for molecular property prediction.
  • By employing adaptive molecular embeddings and rigorous model training and validation methods, ChemPrint substantially outperformed conventional AI approaches.

Alger Expands High-Conviction Growth Equity Lineup with the Launch of the Alger AI Enablers & Adopters and Alger Concentrated Equity Strategies

Retrieved on: 
Monday, April 8, 2024

NEW YORK, April 8, 2024 /PRNewswire-PRWeb/ -- Fred Alger Management, LLC ("Alger"), a privately held $25.7 billion growth equity investment manager, today announced the launch of two high-conviction portfolios: Alger AI Enablers & Adopters and Alger Concentrated Equity. Both strategies are available as ETFs, mutual funds, and separate accounts.

Key Points: 
  • NEW YORK, April 8, 2024 /PRNewswire-PRWeb/ -- Fred Alger Management, LLC ("Alger"), a privately held $25.7 billion growth equity investment manager, today announced the launch of two high-conviction portfolios: Alger AI Enablers & Adopters and Alger Concentrated Equity.
  • Alger AI Enablers & Adopters, managed by Patrick Kelly, CFA, is a focused portfolio of companies actively involved in developing and implementing Artificial Intelligence (AI) technologies.
  • In our view, organizations that embrace AI technologies better position themselves to drive sustainable growth in the digital age.
  • Alger Concentrated Equity is a focused portfolio of 20-30 stocks representing the highest conviction investment ideas of portfolio manager Dr. Ankur Crawford.

Preparing for the next health crisis: COVID-19 showed the importance of community-engaged research

Retrieved on: 
Tuesday, April 9, 2024

Like most activities that require personal interaction, this type of research was disrupted by the restrictions of the COVID-19 pandemic.

Key Points: 
  • Like most activities that require personal interaction, this type of research was disrupted by the restrictions of the COVID-19 pandemic.
  • Community-engaged projects have garnered attention over the past two decades as they focus on tackling inequities, which often arise during public health crises.

Community-engaged research during the pandemic

  • Public health measures focused on preventing the spread of COVID-19 (such as limits on in-person gatherings) halted traditional forms of fieldwork.
  • These organizations are sought after as community research partners since they are embedded in the communities they serve and provide crucial services to community members.
  • Findings from our roundtable, supplementing this article, have also been included in our Community-Engaged Research during Health Crises: Engaging with Civil Society Organizations handbook published by PIPPS and SFU Community Engaged Research Initiative.

Barriers to conducting community-engaged research

  • Roundtable attendees first discussed the challenges of conducting research remotely, with one noting how their research plans were put on pause for more than three months because of pandemic-related restrictions.
  • Several attendees found it difficult to recruit research participants; they discussed the challenges of the digital divide, referring to the gap between communities’ access to information and communication technologies.
  • While ethics applications were expedited, researchers felt they lacked guidance for community-engaged research during the pandemic.

Opportunities emerging from the pandemic

  • Despite the challenges they faced, researchers identified a range of opportunities that emerged as a result of the pandemic.
  • Researchers also discussed how the pandemic forced the “professional veneers to slip away.” Over time, researchers connected on a more vulnerable level with their community partners, as they all attempted to get through the pandemic.
  • Compensating members of the research team for their knowledge strengthened the relevancy of their findings as they directly learned how the pandemic was impacting distinct groups.

Lessons learned: Conducting community-engaged research in future crises

  • Participants were asked what they would do differently in future health crises.
  • Some discussed the significance of holding informal check-ins with their teams to openly discuss professional and personal challenges.
  • Based on the key themes of the roundtable, three recommendations emerged to support community-engaged research in future public health crises: 1) Post-secondary institutions should develop guidance for community-engaged research in health emergencies Since post-secondary institutions increasingly recognize the importance of community-university partnerships, institutions should create protocols to support community-engaged research in public health crises.
  • 2) Develop targeted funding opportunities for community-engaged research partnerships During the pandemic, research unrelated to COVID-19 faced funding drawbacks and resource constraints.
  • Rather than treating community-engaged research as a “peripheral activity,” the principles of community engagement should be embedded in research, teaching and learning.


Julia Smith receives funding from the Canadian Institutes of Health Research and Health Research BC. Simran Purewal does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Brady Corporation Plans to Acquire Gravotech Holding

Retrieved on: 
Friday, March 15, 2024

MILWAUKEE, March 15, 2024 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE: BRC) (“Brady”) announced today that it has entered into exclusive negotiations to acquire Gravotech Holding (“Gravotech”) for approximately EUR 123 million (approximately USD 133 million).

Key Points: 
  • MILWAUKEE, March 15, 2024 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE: BRC) (“Brady”) announced today that it has entered into exclusive negotiations to acquire Gravotech Holding (“Gravotech”) for approximately EUR 123 million (approximately USD 133 million).
  • Brady is a leader in high-performance industrial printers and adhesive materials, and the acquisition of Gravotech will add specialized direct part marking and engraving capabilities to Brady’s extensive product identification offering.
  • Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places.
  • Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2023, employed approximately 5,600 people in its worldwide businesses.

Hurco Companies, Inc. Announces Quarterly Cash Dividend

Retrieved on: 
Friday, March 15, 2024

The dividend will be paid on April 12, 2024, to shareholders of record as of the close of business on March 29, 2024.

Key Points: 
  • The dividend will be paid on April 12, 2024, to shareholders of record as of the close of business on March 29, 2024.
  • Future declarations of dividends are subject to approval of the Board of Directors and may be adjusted as business needs or market conditions change.
  • Hurco Companies, Inc. is an international, industrial technology company that sells its three brands of computer numeric control (“CNC”) machine tools to the worldwide metal cutting and metal forming industry.
  • Two of the Company’s brands of machine tools, Hurco and Milltronics, are equipped with interactive controls that include software that is proprietary to each respective brand.

Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-Consortium

Retrieved on: 
Thursday, March 14, 2024

The BioMap-Consortium has a $20 billion funding ceiling, through which it provides growth funding, as well as streamlined access to servicing government-funded manufacturing programs.

Key Points: 
  • The BioMap-Consortium has a $20 billion funding ceiling, through which it provides growth funding, as well as streamlined access to servicing government-funded manufacturing programs.
  • Scorpius offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state-of-the-art facilities in San Antonio, TX.
  • With an experienced team and new, purpose-built U.S. facilities, Scorpius is dedicated to transparent collaboration and flexible, high-quality biologics biomanufacturing.
  • This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Could python farming offer hope for global food security impacted by climate change?

Retrieved on: 
Thursday, March 14, 2024

CAIRNS, Australia, March 14, 2024 (GLOBE NEWSWIRE) -- New research suggests farming pythons could offer a viable alternative to conventional livestock in parts of the world where the challenges of the climate crisis, pandemics, and degradation of agricultural land are undermining global food production.

Key Points: 
  • CAIRNS, Australia, March 14, 2024 (GLOBE NEWSWIRE) -- New research suggests farming pythons could offer a viable alternative to conventional livestock in parts of the world where the challenges of the climate crisis, pandemics, and degradation of agricultural land are undermining global food production.
  • Dr Natusch is the Chair of the International Union for the Conservation of Nature (IUCN) Snake Specialist Group, comprising the world’s foremost snake experts.
  • “Global food security is predicted to worsen with climate change, and the agricultural sector will also suffer increasing compound effects from infectious diseases and diminishing natural resources,” Dr Natusch said.
  • Video Interview with Dr Dan Natusch: https://we.tl/t-38IfrKHo1T
    Video Interview with Dr Pat Aust: https://we.tl/t-3ijoXec6a5
    Video Footage of python farms: https://we.tl/t-NMuLR0HnOT
    For more information or to schedule interviews with Dr Daniel Natusch please contact:

HarborOne Bancorp, Inc. Announces 6.7% Increase in First Quarter 2024 Dividend

Retrieved on: 
Thursday, March 28, 2024

HarborOne Bancorp, Inc. (the “Company”) (NASDAQ: HONE), the holding company of HarborOne Bank, today announced that its Board of Directors has declared a quarterly cash dividend of $0.08 per share, which represents an increase of $0.005 per share, or 6.7%, compared to its most recent dividend paid on January 18, 2024.

Key Points: 
  • HarborOne Bancorp, Inc. (the “Company”) (NASDAQ: HONE), the holding company of HarborOne Bank, today announced that its Board of Directors has declared a quarterly cash dividend of $0.08 per share, which represents an increase of $0.005 per share, or 6.7%, compared to its most recent dividend paid on January 18, 2024.
  • The dividend will be paid on April 24, 2024 to all shareholders of record as of the close of business on April 10, 2024.
  • “We are very pleased to provide a 6.7% increase to the quarterly cash dividend payment on the Company’s common stock from $0.075 to $0.08 commencing in the first quarter of 2024,” said Joseph F. Casey, President and Chief Executive Officer of the Company.
  • “The dividend increase is supported by our current and projected earnings as we continue executing our business plan.”
    The increased quarterly dividend level equates to an annualized dividend rate of $0.32 per common share.

New Fortress Energy Completes Previously Announced Acquisition and Transfer of 1.6 GW, 15-year Contracted Power Asset in Brazil

Retrieved on: 
Wednesday, March 20, 2024

Construction activities for the 1.6 GW power plant have commenced at NFE’s site adjacent to our existing LNG terminal located in Barcarena, Brazil.

Key Points: 
  • Construction activities for the 1.6 GW power plant have commenced at NFE’s site adjacent to our existing LNG terminal located in Barcarena, Brazil.
  • This transaction represents the value of our operational LNG terminals in Brazil and we appreciate the partnership with Denham Capital to move quickly to transfer this PPA and begin construction,” said Andrew Dete, Managing Director of New Fortress Energy.
  • For additional information on the acquisition, please reference the press release issued on December 27, 2023 on our investor relations website at https://ir.newfortressenergy.com/investor-relations.
  • About New Fortress Energy Inc.
    New Fortress Energy Inc. (NASDAQ: NFE) is a global energy infrastructure company founded to help address energy poverty and accelerate the world’s transition to reliable, affordable, and clean energy.